0001209191-19-048282.txt : 20190904
0001209191-19-048282.hdr.sgml : 20190904
20190904175915
ACCESSION NUMBER: 0001209191-19-048282
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20190903
FILED AS OF DATE: 20190904
DATE AS OF CHANGE: 20190904
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: Dempsey James F.
CENTRAL INDEX KEY: 0001637089
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 001-37725
FILM NUMBER: 191075701
MAIL ADDRESS:
STREET 1: C/O VIEWRAY INCORPORATED
STREET 2: 2 THERMO FISHER WAY
CITY: OAKWOOD VILLAGE
STATE: OH
ZIP: 44146
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: ViewRay, Inc.
CENTRAL INDEX KEY: 0001597313
STANDARD INDUSTRIAL CLASSIFICATION: ELECTROMEDICAL & ELECTROTHERAPEUTIC APPARATUS [3845]
IRS NUMBER: 421777485
STATE OF INCORPORATION: DE
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: 2 THERMO FISHER WAY
CITY: OAKWOOD VILLAGE
STATE: OH
ZIP: 44146
BUSINESS PHONE: 440-703-3210
MAIL ADDRESS:
STREET 1: 2 THERMO FISHER WAY
CITY: OAKWOOD VILLAGE
STATE: OH
ZIP: 44146
FORMER COMPANY:
FORMER CONFORMED NAME: Mirax Corp
DATE OF NAME CHANGE: 20140116
4
1
doc4.xml
FORM 4 SUBMISSION
X0306
4
2019-09-03
0
0001597313
ViewRay, Inc.
VRAY
0001637089
Dempsey James F.
C/O VIEWRAY, INC.
2 THERMO FISHER WAY
OAKWOOD VILLAGE
OH
44146
1
1
0
0
Chief Scientific Officer
Common Stock
2019-09-03
4
M
0
51460
0.68
A
272433
D
Common Stock
2019-09-03
4
S
0
51460
3.566
D
220973
D
Common Stock
2019-09-03
4
M
0
164697
0.68
A
385670
D
Common Stock
2019-09-03
4
S
0
164697
3.566
D
220973
D
Common Stock
2019-09-03
4
M
0
63257
0.70
A
284230
D
Common Stock
2019-09-03
4
S
0
63257
3.566
D
220973
D
Stock Option (right to buy)
0.68
2019-09-03
4
M
0
51460
0.00
D
2020-06-29
Common Stock
61752
0
D
Stock Option (right to buy)
0.68
2019-09-03
4
M
0
164697
0.00
D
2020-06-29
Common Stock
197635
0
D
Stock Option (right to buy)
0.70
2019-09-03
4
M
0
63257
0.00
D
2022-03-01
Common Stock
63257
0
D
The transactions reported were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person.
The reported price in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $3.42 to $3.94 per share, inclusive. The reporting person undertakes to provide to the issuer, any security holder of the issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.
Includes 38,371 shares granted as Restricted Stock Units. As of the transaction date, none of the restricted stock units have vested.
The shares subject to the option vested in 36 monthly installments beginning June 17, 2010 (the "Vesting Commencement Date") and became exercisable on each monthly anniversary thereafter, such that 100% of the shares subject to the option were fully vested on the 36 month anniversary of the Vesting Commencement Date.
The shares subject to the option vested in 48 monthly installments beginning July 14, 2010 (the "Vesting Commencement Date") and became exercisable on each monthly anniversary thereafter, such that 100% of the shares subject to the option were fully vested on the 48 month anniversary of the Vesting Commencement Date.
The shares subject to the option vested in 48 monthly installments beginning March 1, 2012 (the "Vesting Commencement Date") and became exercisable on each monthly anniversary thereafter, such that 100% of the shares subject to the option were fully vested on the 48 month anniversary of the Vesting Commencement Date.
/s/ Robert McCormack, Attorney-in-Fact
2019-09-04